TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
AXSM

Axsome Therapeutics Inc

Healthcare · Biotechnology

170.10$ -1.7% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Axsome Therapeutics Inc (AXSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 761 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AXSM
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
35 38 46 39 33 36 28 22 16 15 44 55 44 221 198 191 204 186 167 143 117 88 89 181 339 331 389 612 601 588 546 548 561 568 597 640 669 690 714 761
35 38 46 39 32 35 28 22 16 15 44 55 44 220 198 191 203 184 165 142 115 87 87 104 252 246 304 520 512 504 460 463 479 485 495 537 565 589 611 657
34 37 45 38 32 34 27 20 15 14 43 54 44 220 197 191 202 184 165 141 115 86 85 73 228 201 247 437 417 386 331 316 327 315 301 303 325 323 305 320
34 37 45 38 32 34 27 20 15 14 43 54 44 220 197 191 202 184 165 141 115 86 85 73 228 201 247 437 417 386 331 316 327 315 301 303 325 323 305 320
– – – – – – – – – – – – – – – – – – – – – – – 16 20 38 45 67 78 95 101 120 124 142 161 199 197 224 251 277
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – 10 2.1 4.3 7.9 9.3 10.0 15 16 15 14 16 16 18 24 28 32 38
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.3 0.3 0.5 0.6 13 1.1 16 16 8.0 – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – 12 12 10 10 12 12 12 12 12 12 12 12 12 12 12 12 12
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – 63 61 60 58 57 55 53 52 50 49 47 45 44 42 41 39 37
6.7 17 17 16 16 19 15 15 15 14 27 30 38 42 42 37 68 72 71 72 74 72 74 165 182 222 277 333 331 397 402 445 469 511 543 567 596 602 659 678
6.7 7.2 8.4 8.2 8.4 12 9.4 9.5 11 11 7.7 13 19 24 26 23 20 23 22 23 25 23 25 43 60 97 101 115 115 139 144 187 196 230 244 342 360 379 439 460
– 0.3 1.1 1.9 2.7 3.3 3.3 3.3 3.3 3.3 0.5 2.2 0.6 2.6 4.6 6.5 – 1.2 1.2 1.1 0.9 0.6 1.0 0.7 0.4 0.4 0.1 0.4 0.4 1.3 1.8 2.6 2.9 3.3 2.3 72 73 73 74 71
3.9 4.1 4.7 4.0 2.9 3.4 3.9 3.2 4.2 3.7 3.4 6.1 9.4 11 12 9.4 11 14 15 12 13 13 13 19 13 39 36 43 29 41 54 61 64 72 86 92 54 66 107 79
0.0 9.5 8.8 8.1 7.4 6.7 5.9 5.2 4.4 3.6 19 17 19 17 16 14 48 48 49 49 49 49 49 93 94 94 148 177 177 178 179 179 180 181 181 118 118 118 118 118
28 22 29 23 17 17 13 7.0 0.7 0.9 17 24 6.8 -176 -208 154 135 114 96 71 43 16 15 15 157 110 112 279 270 191 144 103 93 57 53 73 74 88 55 83
-40 -48 -56 -63 -69 -77 -81 -90 -98 -108 -118 -132 -151 -176 -208 -227 -250 -279 -308 -340 -375 -409 -449 -490 -535 -596 -608 -675 -737 -836 -904 -983 -1,048 -1,123 -1,182 -1,230 -1,277 -1,306 -1,371 -1,422
19 19 20 24 24 24 26 26 26 30 33 34 34 35 37 37 37 37 37 38 38 38 38 39 42 43 44 44 47 47 47 48 48 49 49 49 50 51 51 52

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?